Abstract:Exquisite binding specificity is essential for many protein functions but is difficult to engineer. Many biotechnological or biomedical applications require the discrimination of very similar ligands, which poses the challenge of designing protein sequences with highly specific binding profiles. Experimental methods for generating specific binders rely on in vitro selection, which is limited in terms of library size and control over specificity profiles. Additional control was recently demonstrated through high-throughput sequencing and downstream computational analysis. Here we follow such an approach to demonstrate the design of specific antibodies beyond those probed experimentally. We do so in a context where very similar epitopes need to be discriminated, and where these epitopes cannot be experimentally dissociated from other epitopes present in the selection. Our approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not. Using data from phage display experiments, we show that the model successfully disentangles these modes, even when they are associated with chemically very similar ligands. Additionally, we demonstrate and validate experimentally the computational design of antibodies with customized specificity profiles, either with specific high affinity for a particular target ligand, or with cross-specificity for multiple target ligands. Overall, our results showcase the potential of leveraging a biophysical model learned from selections against multiple ligands to design proteins with tailored specificity, with applications to protein engineering extending beyond the design of antibodies. A great challenge in protein science is to relate sequences to physical properties, both to predict physical properties from sequences, and to design sequences with desired phenotypes. A promising solution lies in integrating large-scale selection experiments, high-throughput sequencing, and machine learning techniques. However, existing models often focus solely on the property under selection ("fitness"), lacking interpretability. This limits our fundamental understanding of proteins and our ability to engineer them for desired properties, especially those not directly selectable in experiments. Previous studies have shown that incorporating biophysical constraints into models can offer quantitative insights, particularly in transcription factors Here, we demonstrate that when coupled with extensive experiments, such modeling can not only predict physical features but also design new proteins with specific properties. Our demonstration involves a problem of primary biotechnological and biomedical interest: the design of antibodies with defined specificity profiles. We focus on one of the most challenging tasks in the field, designing antibodies capable of discriminating between structurally and chemically similar ligands. This approach has applications for creating antibodies with both specific and cross-specific binding properties and for mitigating experimental artifacts and biases in selection experiments. The combination of biophysics-informed modeling and extensive selection experiments holds broad applicability beyond antibodies, offering a powerful toolset for designing proteins with desired physical properties.

Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops

Biochemical and biophysical characterization of natural polyreactivity in antibodies

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions

Antibody CDR loops as ensembles in solution vs. canonical clusters from X-ray structures

Predictability of antigen binding based on short motifs in the antibody CDRH3

Public Baseline and shared response structures support the theory of antibody repertoire functional commonality

Benchmarking antibody clustering methods using sequence, structural, and machine learning similarity measures for antibody discovery applications

Learned features of antibody-antigen binding affinity

Learning the Language of Antibody Hypervariability

Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discovery

Systems Analysis Reveals High Genetic and Antigen-Driven Predetermination of Antibody Repertoires throughout B Cell Development

Computational analysis of epitope-specific T-cell repertoires.

Large-scale analysis of 2,152 Ig-seq datasets reveals key features of B cell biology and the antibody repertoire

Comparative Analysis of the CDR Loops of Antigen Receptors

Inference and design of antibody specificity: From experiments to models and back

Structural diversity of B-cell receptor repertoires along the B-cell differentiation axis in humans and mice

Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies

Repertoire-scale measures of antigen binding

Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies

Large-scale Analysis of 2,152 dataset reveals key features of B cell biology and the antibody repertoire